| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 707465 | 2-Butenoic acid, 4-[[4,5-dichloro-2-[[[[2-(1-pyrrolidinyl)cyclohexyl] (methyl)amino]carbonyl]methyl]phenyl]amino]-4-oxo-, methyl ester, (1S,2S)- | 0.0163859626459254 | 0.33267987 |
| NSC 709100 | Null | 0.0163859626459254 | 0.10427697 |
| NSC 709564 | Null | 0.0163859626459254 | 0.23128172 |
| NSC 720199 | Null | 0.0163859626459254 | 0.19425441 |
| NSC 728040 | 2-[4-(methoxy)phenyltio]-3-phenyl-5,7-diamino quinoxaline | 0.0163859626459254 | 0.22274057 |
| NSC 732517 | Dasatinib | 0.0163859626459254 | -0.18545997 |
| NSC 732698 | 1-{4-[4-chloro-1-(2,4-dichlorobenzyl)-2,5-dioxo-2,5-dihydro- 1H-3-pyrrolylamino]phenylcarboxamido}-3-trifluoromethylbenze ne | 0.0163859626459254 | 0.13265283 |
| NSC 736153 | Null | 0.0163859626459254 | 0.3343649 |
| NSC 743432 | 2-{5-[4-(5-{4-[6-morpholino-1H-benzo[d]imidazole-2-yl]phenoxy}pentyl)piperazino]pentyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione | 0.0163859626459254 | 0.29214791 |
| NSC 743556 | Null | 0.0163859626459254 | 0.20543215 |